How Significant Are Moderna's Asian Regulatory Wins?
Moderna (NASDAQ: MRNA) recently went two for two in Asia. The company picked up an approval in Japan for its COVID-19 vaccine and secured authorization in South Korea. In this Motley Fool Live video, recorded on May 26, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the impact of these regulatory wins for Moderna.
Source Fool.com
